Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 6/2017

01.06.2017 | Pediatric Type 2 and Monogenic Diabetes (PS Zeitler, Section Editor)

Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus

verfasst von: Amy S. Shah, Elaine M. Urbina

Erschienen in: Current Diabetes Reports | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review aims to discuss the burden of type 2 diabetes in youth and summarize the studies that have utilized noninvasive techniques to assess early vascular disease in youth with type 2 diabetes.

Recent Findings

Noninvasive imaging modalities provide researchers with tools to investigate the vasculature in adolescents with type 2 diabetes. The data published to date consistently show adolescents with type 2 diabetes have greater vascular thickness and stiffness and worse endothelial function compared to their obese and lean peers.

Summary

As the prevalence of type 2 diabetes continues to increase adolescent youth, there is concern adolescents with type 2 diabetes are at risk to develop early onset cardiovascular disease and complications. Future studies need to address treatments that have the potential to improve or reverse vascular dysfunction and decrease the rate of cardiovascular disease and complications.
Literatur
1.
Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035–8.CrossRefPubMed
2.
Palumbo PJ, et al. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes. 1976;25(7):566–73.CrossRefPubMed
3.
Gregg EW, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012;35(6):1252–7.CrossRefPubMedPubMedCentral
4.
Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347(17):1342–9.CrossRefPubMed
5.
Biessels GJ, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74.CrossRefPubMed
6.
Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–9.CrossRefPubMed
7.
Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med. 1999;16(2):93–112.CrossRefPubMed
8.
van Elderen SG, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology. 2010;75(11):997–1002.CrossRefPubMed
9.
Ott A, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53(9):1937–42.CrossRefPubMed
10.
11.
Mayer-Davis EJ, et al. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2009;7(2):89–95.CrossRefPubMedPubMedCentral
12.
Hannon TS, Arslanian SA. The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci. 2015;1353:113–37.CrossRefPubMed
13.
Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146(5):693–700.CrossRefPubMed
14.
15.
Copeland KC, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1):159–67.CrossRefPubMed
16.
Pinhas-Hamiel O, et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5 Pt 1):608–15.CrossRefPubMed
17.
Imperatore G, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12):2515–20.CrossRefPubMedPubMedCentral
18.
Amutha A, et al. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes. 2011;5(4):223–9.CrossRefPubMed
19.
Urakami T, et al. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. Pediatr Endocrinol Rev. 2012;10(Suppl 1):51–61.PubMed
20.
Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children–an emerging problem. Diabet Med. 2000;17(12):867–71.CrossRefPubMed
21.
Dabelea D, et al. Increasing prevalence of type II diabetes in American Indian children. Diabetologia. 1998;41(8):904–10.CrossRefPubMed
22.
Kavey RE, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research. J Cardiovasc Nurs. 2007;22(3):218–53.CrossRefPubMed
23.
•• Dart AB, et al. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care. 2014;37(2):436–43. This study provides an update on rates of complications in adolescent type 2 diabetes compared to adolescent type 1 diabetes and controls without diabetes CrossRefPubMed
24.
Constantino MI, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36(12):3863–9.CrossRefPubMedPubMedCentral
25.
Eppens MC, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6):1300–6.CrossRefPubMed
26.
•• Maahs DM, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the american heart association. Circulation. 2014;130(17):1532–58. This study provides a thorough review of the current research on cardiovascular risk factors in youth with type 2 diabetes CrossRefPubMed
27.
Chambless LE, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis isk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146(6):483–94.CrossRefPubMed
28.
O'Leary DH, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340(1):14–22.CrossRefPubMed
29.
Simons PC, et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART study (second manifestations of ARTerial disease). Circulation. 1999;100(9):951–7.CrossRefPubMed
30.
Brinton TJ, et al. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol. 1997;80(3):323–30.CrossRefPubMed
31.
Laurent S, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605.CrossRefPubMed
32.
Kotb NA, et al. Clinical and biochemical predictors of increased carotid intima-media thickness in overweight and obese adolescents with type 2 diabetes. Diab Vasc Dis Res. 2012;9(1):35–41.CrossRefPubMed
33.
Urbina EM, et al. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. 2009;119(22):2913–9.CrossRefPubMedPubMedCentral
34.
Naylor LH, et al. Endothelial function and carotid intima-medial thickness in adolescents with type 2 diabetes mellitus. J Pediatr. 2011;159(6):971–4.CrossRefPubMed
35.
Shah AS, et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(10):3740–5.CrossRefPubMedPubMedCentral
36.
Shah AS, et al. Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus. J Clin Lipidol. 2013;7(5):441–5.CrossRefPubMedPubMedCentral
37.
Gosling RG, Budge MM. Terminology for describing the elastic behavior of arteries. Hypertension. 2003;41(6):1180–2.CrossRefPubMed
38.
Cavallini MC, Roman MJ, Blank SG, Pini R, Pickering TG, Devereux RB. Association of the auscultatory gap with vascular disease in hypertensive patients. Ann Intern Med. 1996;124(10):877–83.CrossRefPubMed
39.
Salomaa V, et al. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC study. Atherosclerosis risk in communities study. Circulation. 1995;91(5):1432–43.CrossRefPubMed
40.
van Dijk RA, et al. Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Investig. 2003;33(4):307–15.CrossRef
41.
McLeod AL, et al. Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens. 2004;22(2):363–8.CrossRefPubMed
42.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.CrossRefPubMed
43.
Urbina EM, et al. Brachial artery distensibility and relation to cardiovascular risk factors in healthy young adults (The Bogalusa Heart Study). Am J Cardiol. 2002;89(8):946–51.CrossRefPubMed
44.
Urbina EM, et al. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010;28(8):1692–8.CrossRefPubMedPubMedCentral
45.
Shah AS, et al. Racial differences in arterial stiffness among adolescents and young adults with type 2 diabetes. Pediatr Diabetes. 2012;13(2):170–5.CrossRefPubMed
46.
47.
Li X, et al. Low-grade inflammation and increased arterial stiffness in Chinese youth and adolescents with newly-diagnosed type 2 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2015;7(4):268–73.CrossRefPubMedPubMedCentral
48.
Skilton MR, Celermajer DS. Endothelial dysfunction and arterial abnormalities in childhood obesity. Int J Obes. 2006;30(7):1041–9.CrossRef
49.
Corretti MC, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–65.CrossRefPubMed
50.
Deanfield J, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(1):7–17.CrossRefPubMed
51.
Cox DA, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation. 1989;80(3):458–65.CrossRefPubMed
52.
Ohsugi K, et al. Comparison of brachial artery flow-mediated dilation in youth with type 1 and type 2 diabetes mellitus. J Diabetes Investig. 2014;5(5):615–20.CrossRefPubMedPubMedCentral
53.
Woo KS, et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord. 2004;28(7):852–7.CrossRefPubMed
54.
Bonetti PO, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137–41.CrossRefPubMed
55.
• Naylor LH, et al. Exercise training improves vascular function in adolescents with type 2 diabetes. Physiol Rep. 2016;4(4):e12713. This article shows exercise trainings are associated with improvements in vascular function CrossRefPubMedPubMedCentral
56.
Seki M, et al. Aortic stiffness and aortic dilation in infants and children with tetralogy of Fallot before corrective surgery: evidence for intrinsically abnormal aortic mechanical property. Eur J Cardiothorac Surg. 2012;41(2):277–82.CrossRefPubMed
57.
Urbina EM, et al. Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr. 2011;158(5):715–21.CrossRefPubMedPubMedCentral
58.
O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl. 1996;14(5):S147–57.PubMed
59.
•• Townsend RR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66(3):698–722. This article summarizes current recommendations for improving and standardizing the use of noninvasive imaging techniques CrossRefPubMedPubMedCentral
Metadaten
Titel
Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus
verfasst von
Amy S. Shah
Elaine M. Urbina
Publikationsdatum
01.06.2017
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 6/2017
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0869-0

Weitere Artikel der Ausgabe 6/2017

Current Diabetes Reports 6/2017 Zur Ausgabe

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus

Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Cell Therapy for Type 1 Diabetes: Current and Future Strategies

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Simultaneous Pancreas and Kidney Transplantation—Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

The Janus Head of Oxidative Stress in Metabolic Diseases and During Physical Exercise

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise